HSPA8P9

Across TCGA pan-cancer cohorts, HSPA8P9 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated HSPA8P9 data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher HSPA8P9 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated HSPA8P9 expression acts as an unfavorable survival marker, although some lineages such as THCA and COAD show a favorable association.

THCA, COAD, and LIHC are the cancer types where HSPA8P9 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	DFS	Median	All	0.947	0.670	.001	69	view →
COAD	OS	Tertile	All	0.920	0.820	.003	55	view →
LIHC	OS	Median	All	0.692	0.858	<.001	47	view →
KIRC	DFS	Median	II,III,IV	0.641	0.355	.001	42	view →
UCS	OS	Median	IV	0.817	0.302	.002	36	view →
UVM	DFS	Median	III,IV	0.430	0.924	.002	34	view →
KICH	DFS	Tertile	II,III,IV	0.591	0.943	.007	31	view →
STAD	OS	Tertile	III,IV	0.268	0.628	.006	26	view →
BRCA	DFS	Tertile	All	0.867	0.914	.015	19	view →
CHOL	DFS	Quartile	All	0.697	0.133	.012	15	view →
READ	OS	Median	IV	0.466	0.824	.006	14	view →
MESO	OS	Median	All	0.456	0.617	.017	13	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

HSPA8P9–THCA (DFS)

Open the THCA breakdown →